Phase III EAGLE trial of Imfinzi in head and neck cancer does not meet primary endpoints Dec. 7, 2018
Novel inhaled PI3Kdelta inhibitor with improved properties for respiratory disease treatment Dec. 7, 2018
Multidomain antibodies with breadth and potency protect mice from a wide array of influenza strains Dec. 7, 2018
Topline results presented from ENCORE-PH phase IIb study in patients with NASH cirrhosis Dec. 7, 2018
Icagen and Roche collaborate to develop and commercialize therapy for neurological diseases Dec. 7, 2018
GMI-1687, a novel inhibitor of E-selectin with promising activity in preclinical models of AML Dec. 7, 2018
RSS